What to Know About Journavx, the Non-Opioid Pain Medication Just Approved by the FDA
The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...
FDA approves first new type of pain medication in 25 years
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will ...
iDiva on MSN10d
Dhanashree Verma Shares About 'Therapeutic' Pottery Experience Amid Divorce Rumours With Yuzvendra Chaha
Dhanashree Verma has been making headlines amid speculations of parting ways with her husband Yuzvendra Chahal. Amid all this ...
FDA approves Vertex's first-in-class non-opioid analgesic for acute pain
Today, the U.S. Food and Drug Administration (FDA) gave its approval to Vertex Pharmaceuticals' (NASDAQ: NASDAQ:VRTX) Journavx (suzetrigine) 50 milligram oral tablets. This new drug is a non-opioid ...
Jhalak Dikhhla Jaa fame Dhanashree Verma tries her hand at something ‘therapeutic’ amid divorce rumors with Yuzvendra Chahal; see video
Dhanashree Verma addressed rumors about her relationship with Yuzvendra Chahal by sharing her pottery class experience on ...
Onlymyhealth10d
Dhanashree Verma Opts For Pottery Therapy Amid Divorce Rumours: Expert Shares How Pottery Helps in Better Mental Health
Dhanashree Verma has taken up pottery therapy calling it therapeutic and encouraging others to explore creative outlets for ...
Manas AI Launches to Transform Discovery of Novel Cancer Medicines
Manas AI, a full-stack, AI-driven company focused on discovering and advancing next generation medicines, launched today. By leveraging its ...
East Idaho News on MSN4d
Local woman brings ‘holotropic breathwork’ to eastern Idaho
MyrLynn Anderson, owner and practitioner at FLY Remedies, offers unique transformative holotropic breathwork classes. She ...
WETM Elmira on MSN7d
Dundee foster parent charged, allegedly sexually abused children
A Dundee man who was a therapeutic foster parent is facing charges for allegedly sexually abusing children under his care.
Stockhead on MSN6d
AdAlta boosts leadership in Q2 FY25 to support growth strategy
FY25 saw AdAlta (ASX:1AD) focus on increasing its corporate muscle, with two new board members and additional advisors ...
manilatimes8d
Allogene Therapeutics Secures U.S. FDA IND Clearance for ALLO-329, Advancing its Next-Generation Allogeneic CAR T into Autoimmune Diseases
Best-in-Class Design to Enhance Therapeutic Benefit and Expand Treatment Potential Across a Range of Autoimmune Disease ...